Vascular endothelial growth factor +936C/T and +405G/C polymorphisms and cancer risk: A meta-analysis

Archives of Medical Research

Volumn 41, Issue 7, 2010, Pages 548-557

  Cao, Chao ^a   Fang, Jing Jing ^a   Ying, Tao ^a   Sun, Shi Fang ^a   Lv, Dan ^a   Chen, Zhong Bo ^a   Ma, Hong Ying ^a   Yu, Yi Ming ^a   Ding, Qun Li ^a   Shu, Li Hua ^a   Deng, Zai Chun ^a  

^a NINGBO UNIVERSITY   (China)

Author keywords

Cancer; Meta analysis; Polymorphism; VEGF

Indexed keywords

VASCULOTROPIN;

ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CLINICAL TRIAL; DATA BASE; EMBASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MEDLINE; META ANALYSIS; MOUTH CANCER; SYSTEMATIC REVIEW;

ALLELES; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; PUBMED; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650119774     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.09.006     Document Type: Article

References (57)

1. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
2. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist 2000, 5(Suppl 1):3-10.
3. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002, 2:795-803.
4. Vincenti V., Cassano C., Rocchi M., et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996, 93:1493-1495.
5. Stevens A., Soden J., Brenchley P.E., et al. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003, 63:812-816.
6. Hofmann G., Langsenlehner U., Renner W., et al. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol 2008, 134:591-595.
7. Chae Y.S., Kim J.G., Sohn S.K., et al. Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci 2008, 23:421-427.
8. Wu G.Y., Hasenberg T., Magdeburg R., et al. Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer. World J Surg 2009, 33:124-129.
9. Dassoulas K., Gazouli M., Rizos S., et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 2009, 48:563-569.
10. Tzanakis N., Gazouli M., Rallis G., et al. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 2006, 94:624-630.
11. Chae Y.S., Kim J.G., Sohn S.K., et al. Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology 2006, 71:266-272.
12. Ke Q., Liang J., Wang L.N., et al. Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog 2008, 47:647-651.
13. Bae S.J., Ahn D.H., Hong S.P., et al. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J 2008, 49:783-791.
14. Tahara T., Shibata T., Nakamura M., et al. Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Mol Carcinog 2009, 48:1030-1037.
15. Al-Moundhri M.S., Al-Nabhani M., Burney I.A., et al. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms-a case-control study in an Omani population. Mol Carcinog 2009, 48:1170-1176.
16. Krippl P., Langsenlehner U., Renner W., et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003, 106:468-471.
17. Jin Q., Hemminki K., Enquist K., et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005, 11:3647-3653.
18. Kataoka N., Cai Q., Wen W., et al. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 2006, 15:1148-1152.
19. Jacobs E.J., Feigelson H.S., Bain E.B., et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res 2006, 8:R22.
20. Balasubramanian S.P., Cox A., Cross S.S., et al. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 2007, 121:1009-1016.
21. Eroĝlu A., Oztürk A., Cam R., et al. Vascular endothelial growth factor gene 936 C/T polymorphism in breast cancer patients. Med Oncol 2008, 25:54-55.
22. Jakubowska A., Gronwald J., Menkiszak J., et al. The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett 2007, 262:71-76.
23. Yapijakis C., Vairaktaris E., Vassiliou S., et al. The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 2007, 133:787-791.
24. Cheng C.Y., Chang C.S., Liu C.J., et al. Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106:79-84.
25. Abe A., Sato K., Habuchi T., et al. Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 2002, 198:181-190.
26. Howell W.M., Bateman A.C., Turner S.J., et al. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 2002, 3:229-232.
27. Sfar S., Hassen E., Saad H., et al. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 2006, 35:21-28.
28. Konac E., Onen H.I., Metindir J., et al. Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers. DNA Cell Biol 2007, 26:453-463.
29. Hsiao P.J., Lu M.Y., Chiang F.Y., et al. Vascular endothelial growth factor gene polymorphisms in thyroid cancer. J Endocrinol 2007, 195:265-270.
30. Zhai R., Liu G., Asomaning K., et al. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis 2008, 29:2330-2334.
31. Hsing A.W., Sakoda L.C., Rashid A., et al. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res 2008, 68:6442-6452.
32. Zhai R., Liu G., Zhou W., et al. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Clin Cancer Res 2008, 14:612-617.
33. Bae S.J., Kim J.W., Kang H., et al. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res 2008, 28:1271-1276.
34. Galimberti S., Nagy B., Palumbo G.A., et al. Vascular endothelial growth factor polymorphisms in mantle cell lymphoma. Acta Haematol 2010, 123:91-95.
35. García-Closas M., Malats N., Real F.X., et al. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 2007, 3:e29.
36. Maltese P., Canestrari E., Ruzzo A., et al. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int J Colorectal Dis 2009, 24:165-170.
37. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955, 19:251-253.
38. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127:820-826.
39. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
40. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
41. Zheng H., Wang Z., Shi X., et al. XRCC1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 2009, 65:268-273.
42. Sutton A.J., Duval S.J., Tweedie R.L., et al. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000, 320:1574-1577.
43. Egger M., Davey Smith G., Schneider M., et al. Bias in meta analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
44. Polterauer S., Grimm C., Mustea A., et al. Vascular endothelial growth factor gene polymorphisms in ovarian cancer. Gynecol Oncol 2007, 105:385-389.
45. Schneider B.P., Radovich M., Sledge G.W., et al. Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 2008, 111:157-163.
46. Diao L.P., Yu X.M., Gao Y.H., et al. Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma. J Cancer Res Clin Oncol 2009, 135:1473-1481.
47. Formento J.L., Etienne-Grimaldi M.C., Francoual M., et al. Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer. Pharmacogenomics 2009, 10:1277-1283.
48. Langsenlehner T., Langsenlehner U., Renner W., et al. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer. Eur J Cancer 2008, 44:1572-1576.
49. Kim J.S., Yim S.V., Koh I.S., et al. Single-nucleotide polymorphisms (SNPs) and haplotype analysis in vascular endothelial growth factor (VEGF) gene in the patients with Parkinson disease and lung cancer. Arch Gerontol Geriatr 2009, 48:287-290.
50. Langsenlehner U., Wolf G., Langsenlehner T., et al. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian " tumor of breast tissue: incidence, genetics, and environmental risk factors" study. Breast Cancer Res Treat 2008, 109:297-304.
51. Amano M., Yoshida S., Kennedy S., et al. Association study of vascular endothelial growth factor gene polymorphisms in endometrial carcinomas in a Japanese population. Eur J Gynaecol Oncol 2008, 29:333-337.
52. Vairaktaris E., Serefoglou Z., Avgoustidis D., et al. Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol 2009, 45:247-253.
53. Nikiteas N.I., Tzanakis N., Theodoropoulos G., et al. Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer 2007, 10:12-17.
54. Eroglu A., Gulec S., Kurtman C., et al. Vascular endothelial growth factor 936 C/T polymorphism in cancer patients. Ann Oncol 2006, 17:1467-1468.
55. Verheul H.M., Jorna A.S., Hoekman K., et al. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 2000, 96:4216-4221.
56. Zhou C., Zhou Y., Li J., et al. The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Tohoku J Exp Med 2009, 219:43-51.
57. Zeidel A., Beilin B., Yardeni I., et al. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand 2002, 46:959-964.